Bentham Science presents Promising Cancer Therapeutic Drug Targets: Recent Advancements, a timely and in-depth resource on the latest strategies in cancer treatment. This comprehensive volume presents emerging therapeutic avenues, novel drug delivery systems, and innovative molecular targeting mechanisms designed to combat cancer more effectively.
Structured around molecular targets and therapeutic pathways, the book provides critical insights into cutting-edge approaches such as exosomal delivery systems, CRISPR/Cas9 gene editing, and immunotoxin therapy. The editors have also included chapters that explain the therapeutic potential of natural compounds. A number of contributions by experts in pharmacology showcase the ability of natural compounds to disrupt cancer progression and enhance treatment responsiveness. Emphasis is also placed on cancer stem cells, apoptosis, and key signaling pathways such as Hippo, Hedgehog, and STAT3.
Key Features:
In-depth exploration of advanced therapeutic tools including CRISPR/Cas9, exosomes, and cancer stem cell-targeted treatments
Detailed insights into natural compounds with anticancer potential
Examination of key signaling pathways and apoptosis mechanisms
Analysis of drug resistance and challenges in targeted therapy
Reference lists for advanced readers.
Discover more about the book here: http://bit.ly/47cAmRI
For review copies, interviews, or media inquiries, please contact Bentham Science Publishers.
About the Editor
Dr. Ashok Kumar Pandurangan
Dr. Ashok Kumar Pandurangan is an Associate Professor at the School of Life Sciences, B.S. Abdur Rahman Crescent Institute of Science and Technology, Vandalur, Chennai, India. He earned his Ph.D. from the Department of Biochemistry, University of Madras, Chennai, and has held prestigious postdoctoral positions at institutions in the United States (Children’s Hospital Oakland Research Institute) and Malaysia (Universiti Putra Malaysia and University of Malaya).
Dr. Pandurangan’s work focuses on cancer biology, with a specific interest in molecular mechanisms of inflammation-induced cancer. He has been recognized among the top 2% of scientists globally by Stanford University for three consecutive years. His academic contributions include over 80 peer-reviewed publications, 28 book chapters, and 5 authored books. He has delivered more than 25 invited lectures and secured multiple research grants across India and Malaysia.
A dedicated mentor, Dr. Pandurangan has supervised 70 undergraduate students, 35 master’s students, and 6 Ph.D. scholars. He continues to contribute to advancing cancer research through his extensive scientific engagement and international collaborations.